Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
COGT
Stock Latest News
The Fly
Cogent Biosciences files automatic mixed securities shelf
17h ago
COGT
Premium
Company Announcements
Cogent Biosciences Advances Precision Therapies in Q3 2025
3d ago
COGT
Premium
Ratings
Cogent Biosciences: Hold Rating Amid Anticipated Positive Data and Pipeline Developments
5d ago
COGT
Premium
The Fly
Cogent Biosciences reports Q3 net loss $80.9M vs. $70.6M last year
5d ago
COGT
Premium
The Fly
Cogent Biosciences sees cash runway into 2027
5d ago
COGT
Premium
Company Announcements
Cogent Biosciences Advances FGFR2/3 Inhibitor Study in Cancer Treatment
12d ago
COGT
Premium
Company Announcements
Cogent Biosciences’ Phase 2 Study on Bezuclastinib: A Potential Game-Changer for Advanced Systemic Mastocytosis
12d ago
COGT
Premium
The Fly
JPMorgan ups Cogent Biosciences target, adds ‘Positive Catalyst Watch’
18d ago
COGT
Premium
Ratings
Promising Outlook for Cogent Biosciences: Buy Rating Backed by FDA Breakthrough Designation and Strong Phase 3 Trial Prospects
19d ago
COGT
Premium
The Fly
Cogent Biosciences announces FDA BTD for bezuclastinib
19d ago
COGT
Premium
The Fly
Cogent Biosciences initiated with a Hold at Stifel
24d ago
COGT
Premium
The Fly
Cogent Biosciences added to Analyst Current Favorites list at Raymond James
2M ago
COGT
Premium
Company Announcements
Cogent Biosciences Signs Lease for New Headquarters
2M ago
8K
COGT
Premium
Ratings
Optimistic Buy Rating for Cogent Biosciences Driven by Bezuclastinib’s Potential and Expected 68.2% Share Price Return
2M ago
COGT
Premium
Ratings
Promising Market Potential for Cogent Biosciences’ Bezuclastinib in Systemic Mastocytosis Treatment
2M ago
COGT
Premium
The Fly
Cogent Biosciences initiated with a Strong Buy at Raymond James
2M ago
COGT
Premium
The Fly
Cogent Biosciences price target raised to $20 from $17 at Guggenheim
3M ago
COGT
Premium
The Fly
Cogent Biosciences price target lowered to $21 from $22 at H.C. Wainwright
3M ago
COGT
Premium
Company Announcements
Cogent Biosciences Reports Increased Losses Amidst Ongoing Development
3M ago
COGT
Premium
Ratings
Promising Pipeline and Financial Stability Drive Buy Rating for Cogent Biosciences
3M ago
COGT
Premium
The Fly
Cogent Biosciences reports Q2 net loss $73.529M vs $58.95M last year
3M ago
COGT
Premium
Ratings
Promising Developments and Undervaluation Drive Buy Rating for Cogent Biosciences
4M ago
COGT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
